Researchers have developed a breakthrough gene-editing strategy to overcome one of the greatest challenges in regenerative medicine: immune rejection. Their solution offers a path toward developing a functional cure for Type 1 diabetes (T1D) without the need for lifelong anti-rejection drugs.

Three U of A startups launched to commercialize innovations developed in the College of Science and the College of Medicine - Tucson have now received an investment that will help them take their next steps and, ideally, lead to follow-on funding. See a video profile of each startup!

A team led by Michael D. L. Johnson is developing a compound that can smuggle an antimicrobial drug through bacteria's defensive shields.

The University of Arizona's senior vice president for research and partnerships joins an elite class of American inventors.

In an expansion of its scope of services, Tech Launch Arizona will now offer incubation services for startups working to bring innovations based on intellectual property developed at the U of A to market.

Startup FutureState is modernizing mobile ID systems and reducing universities' dependence on proprietary vendors. The company’s platform transforms how higher education institutions manage student and staff credentials.